Elizabeth Bolan
Affiliations: | Weill Cornell Graduate School of Medical Sciences |
Google:
"Elizabeth Bolan"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Gavril W. Pasternak | grad student | Weill Cornell Graduate School of Medical Sciences | |
| Toni Shippenberg | post-doc | NIH (NIDA) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kivell B, Uzelac Z, Sundaramurthy S, et al. (2014) Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism. Neuropharmacology. 86: 228-40 |
| Xu J, Xu M, Bolan E, et al. (2014) Isolating and characterizing three alternatively spliced mu opioid receptor variants: mMOR-1A, mMOR-1O, and mMOR-1P. Synapse (New York, N.Y.). 68: 144-52 |
| Zapata A, Kivell B, Han Y, et al. (2007) Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors. The Journal of Biological Chemistry. 282: 35842-54 |
| Bolan EA, Kivell B, Jaligam V, et al. (2007) D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism. Molecular Pharmacology. 71: 1222-32 |
| Pan YX, Xu J, Bolan E, et al. (2005) Identification of four novel exon 5 splice variants of the mouse mu-opioid receptor gene: functional consequences of C-terminal splicing. Molecular Pharmacology. 68: 866-75 |
| Chefer VI, Czyzyk T, Bolan EA, et al. (2005) Endogenous kappa-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 5029-37 |
| Bolan EA, Pan YX, Pasternak GW. (2004) Functional analysis of MOR-1 splice variants of the mouse mu opioid receptor gene Oprm. Synapse (New York, N.Y.). 51: 11-8 |
| Neilan CL, Janvey AJ, Bolan E, et al. (2003) Characterization of the binding of [3H][Dmt1]H-Dmt-D-Arg-Phe-Lys-NH2, a highly potent opioid peptide. The Journal of Pharmacology and Experimental Therapeutics. 306: 430-6 |
| Bolan EA, Tallarida RJ, Pasternak GW. (2002) Synergy between mu opioid ligands: evidence for functional interactions among mu opioid receptor subtypes. The Journal of Pharmacology and Experimental Therapeutics. 303: 557-62 |
| Pan YX, Bolan E, Pasternak GW. (2002) Dimerization of morphine and orphanin FQ/nociceptin receptors: generation of a novel opioid receptor subtype. Biochemical and Biophysical Research Communications. 297: 659-63 |